Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $296.48 | 20 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $98.52 | 7 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $59.91 | 4 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $25.14 | 2 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $23.38 | 2 | $0 (2020) |
| Osiris Therapeutics Inc. | $22.72 | 1 | $0 (2018) |
| Nevro Corp. | $20.16 | 1 | $0 (2020) |
| Amgen Inc. | $16.46 | 1 | $0 (2021) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $15.63 | 1 | $0 (2020) |
| Bayer HealthCare Pharmaceuticals Inc. | $14.56 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $41.16 | 3 | Amgen Inc. ($16.46) |
| 2020 | $218.04 | 15 | Novo Nordisk Inc ($98.52) |
| 2018 | $37.28 | 2 | Osiris Therapeutics Inc. ($22.72) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/13/2021 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Neuroscience | ||||||
| 03/09/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/23/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/01/2020 | Nevro Corp. | Senza Spinal Cord Stimulation System (Device) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/24/2020 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.63 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/05/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: Diabetes | ||||||
| 11/04/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/05/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: Diabetes | ||||||
| 09/15/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Diabetes | ||||||
| 09/01/2020 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.61 | General |
| 08/10/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Endocrinology | ||||||
| 07/29/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Diabetes | ||||||
| 07/15/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Diabetes | ||||||
| 07/07/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/18/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: Respiratory | ||||||
| 06/04/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Diabetes | ||||||
| 02/27/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Endocrinology | ||||||
| 01/30/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Endocrinology | ||||||
| 08/03/2018 | Bayer HealthCare Pharmaceuticals Inc. | Kyleena (Drug), Mirena | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Women's Health | ||||||
| 05/21/2018 | Osiris Therapeutics Inc. | GRAFIX/GRAFIXPL/STRAVIX (Biological) | Food and Beverage | Cash or cash equivalent | $22.72 | General |
| Category: WOUND CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 89 | 139 | $27,767 | $9,215 |
| 2022 | 4 | 91 | 156 | $33,126 | $8,998 |
| 2021 | 2 | 33 | 75 | $16,572 | $5,714 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 54 | $8,154 | $3,167 | 38.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 29 | 44 | $8,800 | $2,483 | 28.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 14 | $5,950 | $1,866 | 31.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 12 | 12 | $2,700 | $1,051 | 38.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 12 | 15 | $2,163 | $648.39 | 30.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 19 | 59 | $12,862 | $4,632 | 36.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 41 | 53 | $13,091 | $2,340 | 17.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 11 | 21 | $3,171 | $1,146 | 36.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 20 | 23 | $4,002 | $878.82 | 22.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 13 | 55 | $11,990 | $4,409 | 36.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 20 | 20 | $4,582 | $1,305 | 28.5% |
About Dr. Mary Masterman, M.D
Dr. Mary Masterman, M.D is a Family Medicine healthcare provider based in Chickasha, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2016. The National Provider Identifier (NPI) number assigned to this provider is 1225487655.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mary Masterman, M.D has received a total of $296.48 in payments from pharmaceutical and medical device companies, with $41.16 received in 2021. These payments were reported across 20 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($296.48).
As a Medicare-enrolled provider, Masterman has provided services to 213 Medicare beneficiaries, totaling 370 services with total Medicare billing of $23,926. Data is available for 3 years (2021–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Chickasha, OK
- Active Since 06/07/2016
- Last Updated 08/06/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1225487655
Products in Payments
- Ozempic (Drug) $84.91
- SOLIQUA 100/33 (Biological) $59.91
- XARELTO (Drug) $25.14
- GRAFIX/GRAFIXPL/STRAVIX (Biological) $22.72
- Senza Spinal Cord Stimulation System (Device) $20.16
- Aimovig (Biological) $16.46
- LifeVest (Device) $15.63
- Kyleena (Drug) $14.56
- SYMBICORT (Drug) $12.33
- FARXIGA (Drug) $11.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Chickasha
Mitchell Coppedge, Md, MD
Family Medicine — Payments: $3,470
Mrs. Abby Housman, D.o, D.O
Family Medicine — Payments: $2,876
Kevin Anderson, D.o, D.O
Family Medicine — Payments: $2,036
Kacey Wallace, Do, DO
Family Medicine — Payments: $1,650
Jonathan Soekamto, Do, DO
Family Medicine — Payments: $747.24
Jeffrey Miller, Md, MD
Family Medicine — Payments: $593.08